Petrelintide
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
Roche · Phase 1 · Completed · Enrollment 48
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Arm A | n/r | n/r | n/r | n/r |
| Arm B | n/r | n/r | n/r | n/r |
| Arm C | n/r | n/r | n/r | n/r |
| Arm D | n/r | n/r | n/r | n/r |
Not shown
- Arm A: endpoint not reported
- Arm B: endpoint not reported
- Arm C: endpoint not reported
- Arm D: endpoint not reported